56,99 €
As our understanding of the human body broadens, so does the need for a comprehensive text that encompasses all aspects of human development. Essential Human Development is a great course companion that focuses on the human life cycle, ideal for the undergraduate student new to these fields, or for qualified practitioners looking for a reference guide.
Featuring key information points and self-test assessments in each chapter, the book is organised in an accessible manner, beginning with fertilisation and embryology, then moving on to obstetric medicine, neonatal care and child health, with the final section exploring gynaecological medicine.
Ensuring that information is placed in context to aid understanding, Essential Human Development is the perfect support for the modern medical school curriculum, as well as a vital reminder of the core information needed whilst on a women or child health clinical placement.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 1220
Veröffentlichungsjahr: 2018
Cover
Title Page
Copyright
List of Contributors
Preface
How to Use Your Textbook
About the Companion Website
Part 1: Fertilisation
Chapter 1: Principles of Development
Case
Chromosomes
Mitosis
Meiosis
Spermatogenesis
Oogenesis
Growth
Differentiation
Signalling
Organisation
Morphogenesis
Chapter 2: The Female Reproductive System
Case
Anatomy
Physiology
Chapter 3: The Male Reproductive System
Case
Anatomy
Embryology
Physiology
Chapter 4: Fertilisation
Case
Anatomy
Cell Biology
Physiology of Fertilisation and the Endometrium
Chapter 5: Embryology: Zygote to Blastocyst
Case
Zygote
Decidualisation
Implantation
Placenta
Sacs of the Embryo
Chapter 6: Embryonic Stem Cells
Case
Embryonic Stem Cells
Stem Cells in Medicine
Ethical Arguments
Law
Part 2: Pregnancy
Chapter 7: Embryology
Case
Embryological Development
Gastrulation
Embryology of the Gastrointestinal System
Neuroembryology
Cardiovascular Embryology
Respiratory Embryology
Musculoskeletal Embryology
Urogenital Embryology
Chapter 8: Physiology of Pregnancy
Case
Systemic Changes During Pregnancy
Chapter 9: Antenatal Care
Case
Assessment of Risk
History
Examination and Investigations
Chapter 10: Antenatal Screening and Prenatal Diagnosis
Case
Obstetric Ultrasound Screening for Fetal Anomaly
Screening for Chromosomal Anomalies
Invasive Tests
Infection in Pregnancy
Chapter 11: Hypertensive Disorders of Pregnancy
Case
Introduction
Definitions
Risks of Hypertension in Pregnancy
Pathology of Pre-Eclampsia and Eclampsia
Clinical Picture
Management
Care During Delivery
Care After Delivery
Chapter 12: Diseases in Pregnancy I
Case
Diabetes in Pregnancy
Chapter 13: Diseases in Pregnancy II
Case
Connective Tissue Disorders
Backache
Carpal Tunnel Syndrome
Hyperemesis Gravidarum
Gastroesophageal Reflux Disease (GORD)
Constipation
Haemorrhoids
Varicose Veins, Varicosities
Dermatological Conditions in Pregnancy
Psychiatric Disease in Pregnancy
Chapter 14: Multiple Pregnancy and Other Antenatal Complications
Case
Incidence of Twins and Chorionicity
Identification of Twin Conception
Risks to the Fetus
Risks to the Mother
Chapter 15: Problems in Late Pregnancy
Case
Antepartum Haemorrhage
Placenta Praevia
Adherent Placenta
Abruptio Placentae
Vasa Praevia
Other Causes of Antepartum Haemorrhage
Reduced Fetal Movements
Prolonged Pregnancy
Chapter 16: Fetal Growth and Tests of Fetal Wellbeing
Case
Definition and Types of Fetal Growth Restriction
Diagnosis of Fetal Growth Restriction
Screening for Fetal Growth Restriction
Fetal Surveillance
Management of Fetal Growth Restriction
Chapter 17: The Eye in Pregnancy and the Newborn
Case
Differential Diagnosis of Paediatric Leucocoria
Case
Introduction
Physiological Changes
Pregnancy-Specific Ocular Disease
Pre-Existing Ocular Disease During Pregnancy
Part 3: Birth
Chapter 18: Normal Labour
Case
Labour
Definitions
Mechanism of Normal Labour
Management of Labour
The Partogram and its Importance
Analgesia in Labour
Useful Drugs in Obstetrics and their Actions
Chapter 19: Abnormal Labour
Case
Definitions
Diagnosis
Causes of Abnormal Labour
Types of Abnormal Labour
Preterm Labour
Prevention and Prediction of Preterm Labour
Induction of Labour
Chapter 20: The Puerperium
Case Study
Physiological Changes
Postnatal Care
Psychological Wellbeing
Lactation and Breastfeeding
Secondary Postpartum Haemorrhage (PPH)
Sepsis
Thrombotic Conditions
Peripartum Cardiomyopathy
Chapter 21: Obstetric Emergencies
Case
Initial Management of Obstetric Emergencies
Causes of Maternal Collapse
Massive Obstetric Haemorrhage
Venous Thromboembolism
Shoulder Dystocia
Cord Prolapse
Amniotic Fluid Embolism
Uterine Inversion
Fetal Distress in the Second Twin
Part 4: Neonatology
Chapter 22: Newborn Resuscitation and Newborn Examination
Case
Newborn Resuscitation
Examination of the Newborn
Chapter 23: Newborn Feeding, Jaundice and Maternal Diabetes
Case
Introduction
Breastfeeding
Formula Feeding
Vitamin K
Vitamin D
Weaning and Milk Feeding in Older Infants
Neonatal Jaundice
Haemolytic Disease of the Newborn (HDN)
Normal Growth and Maturity
Infants of Mothers with Diabetes
Chapter 24: The Preterm Infant
Case
Introduction
Preterm Labour
Antenatal Steroid Therapy
Care at Birth
Respiratory Distress Syndrome
Apnoea of Prematurity
Fluid Management and Nutrition
Patent Ductus Arteriosus
Bronchopulmonary Dysplasia (BPD)
Necrotising Enterocolitis (NEC)
Retinopathy of Prematurity (ROP)
Outcomes Following Extreme Preterm Birth
Discharge of the Preterm Baby From Hospital
Chapter 25: Congenital and Perinatal Infection
Case
Introduction
Congenital Infection
Cytomegalovirus (CMV)
Rubella
Toxoplasmosis
Syphilis
Other Viral Infections
Early-Onset Sepsis
Late-Onset Sepsis
Part 5: Childhood and Adolescence
Chapter 26: History and Examination in Childhood
Case
Introduction
The Paediatric History
The Paediatric Examination
Cardiovascular Examination
Respiratory Examination
Gastrointestinal Examination
Neurological Examination
Ear and Throat Examination
Skin and Musculoskeletal System
Chapter 27: Normal Growth and Developmental Milestones
Case
Growth
Physiology of Growth
Periods of Growth
Measuring Growth
Development
Chapter 28: Developmental Delay
Case
Normal Development
Developmental Delay
Assessing Development
Investigations
Education
Chapter 29: Genetics
Case
Introduction
Clinical Genetics and Genetic Tests
Ethics
Dysmorphology
Genetic Mutations
Genetic Disorders
Techniques Used for Genetic Testing
Chapter 30: Neurodevelopmental Disorders
Case
Learning Disability/Intellectual Disability (LD/ID)
Autism Spectrum Disorder (ASD)
Attention Deficit Hyperactivity Disorder (ADHD)
Developmental Coordination Disorder
Chapter 31: Puberty
Case History
Introduction
Normal Puberty
Assessment of Puberty
Abnormal Puberty
The Psychology of Adolescence
Adolescent Healthcare
Chapter 32: Non-Accidental Injury and Neglect
Case
Introduction
Incidence
Important Legislation
Vulnerable Groups
Types of Abuse
Actions Required if you are Concerned about a Child
Chapter 33: Neurological Problems
Case
Headache
Fits, Faints and Funny Turns
The Epilepsies
Cerebral Palsy
Neuromuscular Diseases in Children
Muscle Disorders
Neural Tube Defects and Hydrocephalus
Chapter 34: Infections and Immunodeficiency
Case
Measles
Mumps
Human Herpes Virus
Varicella Zoster (Chickenpox)
Epstein–Barr Virus (EBV)
Parvovirus B19
Meningitis and Meningococcal Septicaemia
Immune Deficiencies in Children
Chapter 35: Haematology and Oncology
Case
Introduction
Anaemia in Children
Iron Deficiency Anaemia (IDA)
Megaloblastic Anaemia
Anaemia Caused by Increased red Cell Destruction (Haemolytic Anaemia)
Bleeding Disorders
Oncology
Chapter 36: Congenital and Acquired Heart Disease
Case
The Fetal Circulation
Changes at Birth
Heart Disease in Children
Ventricular Septal Defect (VSD).
Other ‘Left-to-Right’ Heart Lesions
Pulmonary Stenosis (PS)
Coarctation of the Aorta
Aortic Stenosis
Cyanotic Heart Lesions
Tetralogy of Fallot
Transposition of the Great Arteries (TGA)
Total Anomalous Pulmonary Venous Connection
Tricuspid Atresia
Hypoplastic Left Heart Syndrome
Truncus Arteriosus
Arrhythmias
The Innocent Heart Murmur
Chapter 37: Metabolic and Endocrine Disorders
Case
Introduction to Endocrinology
Obesity
Diabetes Mellitus
Hypoglycaemia
The Thyroid Gland
Calcium Homeostasis
Hypocalcaemia
Hypercalcaemia
Parathyroid Disorders
Multiple Endocrine Neoplasias
Von Hippel–Lindau Syndrome
The Adrenal Gland
Hypopituitarism
Diabetes Insipidus
Syndrome of Inappropriate ADH
Metabolic Disease
Chapter 38: Respiratory Problems
Case
Introduction
Upper Airway Disorders
Bronchiolitis
Pneumonia
Cystic Fibrosis
Chapter 39: Gastroenterology, Nutrition and Faltering Growth
Case
Introduction
Vomiting
Malabsorption
Cow's Milk Protein Allergy (CMPA)
Post-Gastroenteritis Syndrome
Inflammatory Bowel Disease (IBD)
Gastroenteritis
Other Causes of Diarrhoea
Toddler Diarrhoea
Constipation
Abdominal Pain
Gastrointestinal Bleeding
Meckel's Diverticulum
Faltering Growth
Malnutrition
Chapter 40: Renal and Urinary Problems
Case
Urinary Tract Infections
Abnormalities of the Urinary Tract
Antenatal Detection of Renal Abnormalities
Haematuria
Glomerulonephritis
Henoch–Schönlein Purpura (HSP)
Proteinuria
Acute Renal Failure (ARF)
Chronic Renal Failure (CRF)
Hypertension
Chapter 41: Dermatology
Case
How to Describe Skin Lesions
Dermatological Conditions in Infants and Children
Inflammatory Skin Conditions
Bacterial Skin Infections
Viral Skin Infections
Skin Manifestations of Viral Illnesses
Fungal Skin Infections
Skin Infestations
Neonatal Skin Conditions
Hair Disorders
Skin Manifestations of Systemic Conditions
Bullous Skin Disorders
Chapter 42: Rheumatology and Orthopaedics
Case
Introduction
Paediatric Orthopaedic and Rheumatology Conditions
The Limping Child
Hip Conditions
Leg Pain
Back Pain
Fractures in Non-Accidental Injury (NAI)
Juvenile Idiopathic Arthritis (JIA)
Bone Tumours
Infections
Neonatal Problems
Inherited Disorders
Chapter 43: Paediatric Surgery
Case
Gastrointestinal Conditions
Urological Conditions
Chapter 44: Paediatric Pharmacology
Case
Introduction
Pharmacokinetics
Absorption and Administration
Distribution
Metabolism and Excretion
Pharmacodynamics
Intravenous Fluids
Calculating the Deficit in Dehydration
NPSA Alert (National Patient Safety Agency)
Part 6: Gynaecology
Chapter 45: Problems in Early Pregnancy
Case
Introduction
Embryology
Development of Placenta and Membranes
Relevant Endocrinology
Miscarriage
Ectopic Pregnancy
Hyperemesis Gravidarum
Gestational Trophoblastic Disease
Summary of Approach to Common Problems in Early Pregnancy
Chapter 46: Subfertility
Case
Introduction
History of Assisted Reproduction
Changing Reproductive Behaviour
Prevalence
The Hypothalamo-Pituitary-Gonadal Axis
Factors Affecting Fertility
Types of Subfertility
Chapter 47: Vaginal Discharge, Pelvic Pain and Endometriosis
Case
Vaginal Discharge
Endometriosis
Chapter 48: Termination of Pregnancy
Case
Introduction
Legal Considerations
Ethical Considerations
Termination for Fetal Abnormalities
Termination of Pregnancy: The Global View
Indications for Termination of Pregnancy
The Process for Termination of Pregnancy
Complications of Medical and Surgical Termination of Pregnancy
Common Physical Symptoms After Termination of Pregnancy (TOP)
Complications of TOP
Focus on Infection
Psychological Sequelae of Termination of Pregnancy
Chapter 49: Contraception
Case
Natural Family Planning (or ‘Rhythm Methods’)
Barrier Methods
Combined Oral Methods
Progesterone-Only Pills
Long-Acting Reversible Contraception (Larc)
Emergency/Postcoital Contraception
Sterilisation
Chapter 50: Obstetric and Gynaecological Operations
Case
Episiotomy
Operative or Assisted Vaginal Delivery
Caesarean Section
Hysteroscopy
Laparoscopy
Abdominal and Vaginal Hysterectomy
Surgical Prolapse Procedure
Uterovaginal Prolapse Surgeries
Surgery for Stress Incontinence
Chapter 51: The Menopause
Case
Introduction
History Taking
Investigations
Diagnosis
Premature Ovarian Failure (POF)
Resistant Ovarian Syndrome
Assessment of Women for Hormone Replacement Therapy (HRT)
Alternative Therapies
Further Reading
References
Index
End User License Agreement
Table 9.1
Table 10.1
Table 10.2
Table 10.3
Table 10.4
Table 10.5
Table 10.6
Table 10.7
Table 10.8
Table 10.9
Table 11.1
Table 11.2
Table 11.3
Table 12.1
Table 12.2
Table 12.3
Table 12.4
Table 13.1
Table 13.2
Table 13.3
Table 13.4
Table 13.5
Table 13.6
Table 15.1
Table 15.2
Table 15.3
Table 15.4
Table 15.5
Table 15.6
Table 16.1
Table 16.2
Table 17.1
Table 17.2
Table 17.2
Table 18.1
Table 18.2
Table 19.1
Table 19.2
Table 19.3
Table 22.1
Table 22.2
Table 23.1
Table 24.1
Table 25.1
Table 25.2
Table 26.1
Table 26.2
Table 27.1
Table 27.2
Table 27.3
Table 27.4
Table 27.5
Table 27.6
Table 27.7
Table 27.8
Table 28.1
Table 28.2
Table 28.3
Table 28.4
Table 28.5
Table 33.1
Table 33.1
Table 33.2
Table 33.3
Table 33.4
Table 33.5
Table 33.6
Table 33.7
Table 33.8
Table 33.9
Table 33.10
Table 34.1
Table 34.2
Table 34.3
Table 34.4
Table 35.1
Table 37.1
Table 37.2
Table 37.3
Table 37.4
Table 38.1
Table 38.2
Table 38.3
Table 38.4
Table 39.1
Table 39.2
Table 39.3
Table 39.4
Table 39.5
Table 39.6
Table 39.7
Table 39.8
Table 40.1
Table 40.2
Table 40.3
Table 40.4
Table 44.1
Table 44.2
Table 45.1
Table 45.2
Table 45.3
Table 45.4
Table 45.5
Table 45.6
Table 45.7
Table 45.8
Table 47.1
Table 47.2
Table 47.3
Table 48.1
Table 48.2
Table 49.1
Table 50.1
Table 51.1
Figure 1.1
Figure 1.2
Figure 1.3
Figure 1.4
Figure 1.5
Figure 1.6
Figure 1.7
Figure 2.1
Figure 2.2
Figure 2.3
Figure 2.4
Figure 2.5
Figure 2.6
Figure 2.7
Figure 2.8
Figure 2.9
Figure 2.10
Figure 2.11
Figure 2.12
Figure 2.13
Figure 2.14
Figure 3.1
Figure 3.2
Figure 3.3
Figure 3.4
Figure 4.1
Figure 4.2
Figure 4.3
Figure 4.4
Figure 5.1
Figure 5.2
Figure 5.3
Figure 5.4
Figure 6.1
Figure 6.2
Figure 6.3
Figure 7.1
Figure 7.2
Figure 7.3
Figure 7.4
Figure 7.5
Figure 7.6
Figure 7.7
Figure 7.8
Figure 7.9
Figure 8.1
Figure 8.2
Figure 9.1
Figure 9.2
Figure 10.1
Figure 14.1
Figure 14.2
Figure 15.1
Figure 15.2
Figure 15.3
Figure 16.1
Figure 16.2
Figure 16.3
Figure 16.4
Figure 17.1
Figure 17.2
Figure 17.3
Figure 17.4
Figure 17.5
Figure 17.6
Figure 17.7
Figure 17.8
Figure 17.9
Figure 17.10
Figure 17.11
Figure 17.12
Figure 17.13
Figure 17.14
Figure 17.15
Figure 17.16
Figure 18.1
Figure 18.2
Figure 18.3
Figure 18.4
Figure 19.1
Figure 19.2
Figure 19.3
Figure 19.4
Figure 19.5
Figure 20.1
Figure 20.2
Figure 21.1
Figure 21.2
Figure 21.3
Figure 21.4
Figure 21.5
Figure 22.1
Figure 22.2
Figure 22.3
Figure 22.4
Figure 22.5
Figure 22.6
Figure 22.7
Figure 23.1
Figure 24.1
Figure 26.1
Figure 26.2
Figure 26.3
Figure 27.1
Figure 27.2
Figure 27.3
Figure 28.1
Figure 28.2
Figure 29.1
Figure 29.2
Figure 29.3
Figure 29.4
Figure 31.1
Figure 31.2
Figure 31.3
Figure 31.4
Figure 32.1
Figure 32.2
Figure 32.3
Figure 33.1
Figure 33.2
Figure 33.3
Figure 33.4
Figure 33.5
Figure 34.1
Figure 34.2
Figure 34.3
Figure 34.4
Figure 34.5
Figure 34.6
Figure 35.1
Figure 35.2
Figure 35.3
Figure 35.4
Figure 35.5
Figure 36.1
Figure 36.2
Figure 36.3
Figure 36.4
Figure 36.5
Figure 36.6
Figure 36.7
Figure 36.8
Figure 36.9
Figure 37.1
Figure 37.2
Figure 37.3
Figure 37.4
Figure 37.5
Figure 37.6
Figure 37.7
Figure 38.1
Figure 39.1
Figure 39.2
Figure 39.3
Figure 39.4
Figure 39.5
Figure 39.6
Figure 39.7
Figure 40.1
Figure 40.2
Figure 40.3
Figure 40.4
Figure 41.1
Figure 41.2
Figure 41.3
Figure 41.4
Figure 41.5
Figure 41.6
Figure 41.7
Figure 41.8
Figure 41.9
Figure 42.1
Figure 42.2
Figure 43.1
Figure 43.2
Figure 43.3
Figure 43.4
Figure 43.5
Figure 43.6
Figure 45.1
Figure 45.2
Figure 46.1
Figure 46.2
Figure 46.3
Figure 46.4
Figure 46.5
Figure 49.1
Figure 49.2
Figure 50.1
Figure 50.2
Figure 50.3
Figure 50.4
Figure 50.5
Figure 50.6
Cover
Table of Contents
Begin Reading
Part 1
Chapter 1
iii
iv
ix
x
xi
xii
xiii
xiv
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
137
138
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
Edited by
Samuel Webster
PhD, FHEA
Senior Lecturer in Anatomy & Embryology Swansea University Medical School Swansea, UK
Geraint Morris
MB, BCh, FRCPCH
Consultant Neonatologist and Clinical Director, Children's Services Singleton Hospital Swansea, UK
Euan Kevelighan
FRCOG, FAcadMed, DipMed Ed
All Wales Head of School & Associate Dean for Obstetrics and Gynaecology Honorary Associate Professor, Swansea University Medical School Honorary Secretary of Welsh Obstetrics and Gynaecology Society Swansea, UK
This edition first published 2018
© 2018 John Wiley & Sons Ltd
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of Samuel Webster, Geraint Morris, Euan Kevelighan to be identified as the authors of the editorial material in this work has been asserted in accordance with law.
Registered Office(s)
John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA
John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial Office
9600 Garsington Road, Oxford, OX4 2DQ, UK
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Wiley also publishes its books in a variety of electronic formats and by print-on-demand. Some content that appears in standard print versions of this book may not be available in other formats.
Limit of Liability/Disclaimer of Warranty
The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting scientific method, diagnosis, or treatment by physicians for any particular patient. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
Library of Congress Cataloging-in-Publication Data
Names: Webster, Samuel, 1974- editor. | Morris, Geraint, editor. | Kevelighan, Euan, editor.
Title: Essential human development / edited by Samuel Webster, Geraint Morris, Euan Kevelighan.
Description: Hoboken, NJ : John Wiley & Sons, 2018. | Includes index. | Identifiers: LCCN 2017022080 (print) | LCCN 2017037734 (ebook) | ISBN 9781118528600 (pdf) | ISBN 9781118528617 (epub) | ISBN 9781118528624 (pbk.)
Subjects: LCSH: Life cycle, Human. | Developmental biology. | Embryology, Human.
Classification: LCC QP83.8 (ebook) | LCC QP83.8 .E87 2018 (print) | DDC 571.8–dc23
LC record available at https://lccn.loc.gov/2017022080 9781118528624
Cover image: © Nicholas Eveleigh/Gettyimages
Cover design by Wiley
Rebecca Balfour, MB BCh MRCPCH
Specialty Doctor, Community Child Health
Singleton Hospital
Swansea, UK
Marion Beard, MB BS
Consultant Obstetrician & Gynaecologist
Cardiff and Vale University Health Board
Cardiff, UK
Dana Beasley, State Examination Medicine MRCPCH
Consultant Paediatrician
Morriston Hospital
Swansea, UK
Christopher Bidder, BMedSci BM BS MRCPCH
Consultant Paediatrician with Special Interest in Diabetes and Endocrinology
Morriston Hospital
Swansea, UK
Aisling Carroll-Downey, MB BCh
Belfast City Hospital
Belfast Health and Social Care Trust
Belfast, County Antrim, Northern Ireland
Benjamin Chisholme, MB BCh, BSc (Hons), DRCOG, MRCGP
General Practitioner
Llynfi Surgery
Maesteg
Wales, UK
Jennifer Davies-Oliveira, MB BCh
Speciality Registrar in Obstetrics & Gynaecology
Cardiff and Vale University Health Board
Cardiff , UK
Maitreyee Deshpande, MB BS
Specialty Registrar in Obstetrics & Gynaecology
Cardiff and Vale University Health Board
Cardiff, UK
Jamie Evans, MB BCh MRCPCH
Specialty Registrar, Neonatal Medicine
University Hospital of Wales
Cardiff, Wales, UK
Ruth Frazer, MB BCh
Consultant in Contraception and Sexual Health
Morriston Hospital
Swansea, UK
Nitin Goel, MBBS MD FRCPCH
Consultant Neonatologist
Singleton Hospital
Swansea, UK
Fran Hodge, MB BS
Consultant Obstetrician & Gynaecologist
Morriston Hospital
Swansea, UK
Sharif Ismail, MB BS
Consultant Obstetrician & Gynaecologist
Brighton and Sussex University Hospitals NHS Trust
Sussex, UK
Nisha Kadwadkar, MB BS
Consultant Obstetrician & Gynaecologist
Lancaster Hospital
Lancaster, UK
Euan Kevelighan, FRCOG FAcadMed DipMed Ed
All Wales Head of School & Associate Dean for Obstetrics and Gynaecology
Honorary Associate Professor, Swansea University Medical School
Honorary Secretary of Welsh Obstetrics and Gynaecology Society
Swansea, UK
Aleksandra Komarzyniec-Pyzik, MD Poland, FRSH Dip
Specialty Doctor Obstetrics & Gynaecology
Nevill Hall Hospital
Aneurin Bevan University Health Board
Abergavenny, UK
Franz Majoko, MB BS†
Consultant Obstetrician & Gynaecologist
Formerly of Morriston Hospital
Swansea, UK
Colm McAlinden, MD MB BCh BSc (Hons) MSc, PhD MRCOphth
Visiting Professor
School of Ophthalmology and Optometry
Wenzhou Medical University, China
Geraint Morris, MB BCh FRCPCH
Consultant Neonatologist and Clinical Director, Children's Services
Singleton Hospital
Swansea, UK
Ian Morris, MB BS (Hons) MRCPCH
Consultant Neonatologist
University Hospital of Wales
Cardiff, UK
Marsham Moselhi, MB BS
Consultant Obstetrician & Gynaecologist
Morriston Hospital
Swansea, UK
Deepa Balachandran Nair, MB BS
Registrar in Obstetrics and Gynaecology
Morriston Hospital
Swansea, UK
Manju Nair, MB BS
Consultant Obstetrician & Gynaecologist
Morriston Hospital
Swansea, UK
Cerys Scarr, MB BS
Consultant Obstetrician & Gynaecologist
Royal Gwent Hospital
Newport, UK
Lakshmipriya Selvarajan, MBBS MRCPCH
Specialty Registrar, Paediatric Gastroenterology
Birmingham Children's Hospital
Birmingham, UK
Catrin Simpson, MB BCh BSc (hons) MRCPCH
Consultant Community Paediatrician
Cardiff and Vale University Health Board
Cardiff, UK
Gurpreet Singh Kalra, MB BS
Consultant Gynaecologist
Morriston Hospital
Swansea, UK
Alan Treharne, MB BS
Specialty Registrar, Obstetrics and Gynaecology
St Georges Hospital Medical School
Cardiff, UK
Surekha Tuohy, MB BS MRCPCH
Consultant Community Paediatrician
Singleton Hospital
Swansea, UK
Pramodh Vallabhaneni, MB BS MRCPCH Dip Medical Education
Consultant Paediatrician
Morriston Hospital
Swansea, UK
Sophie Walker MB BS
Clinical Research Fellow
Queen Mary University of London
London, UK
Samuel Webster, PhD FHEA
Senior Lecturer in Anatomy & Embryology
Swansea University Medical School
Swansea, UK
Shabeena Webster, MBBCh MRCPCH Dip Paed Neurodis
Specialty Registrar, Community Paediatrics
Llandough Hospital
Cardiff, UK
Cathy White, MB BS FRCP FRCPCH
Consultant Paediatric Neurologist
Morriston Hospital
Swansea, UK
Bethan Williams, MB BCh MRCPCH
Consultant Community Paediatrician
Cardiff and Vale University Health Board
Cardiff, UK
Toni Williams, MB BCh MRCPCH
Consultant Paediatrician
Glangwili Hospital
Carmarthen, UK
Kinza Younas, MB BS
Consultant Obstetrician & Gynaecologist
Morriston Hospital
Swansea, UK
†Recently deceased.
Medical education is forever expanding as our understanding of medicine and the human body broadens. Books become larger, thicker and are continually updated. This book combines subject areas associated with biological human development for the undergraduate student new to these fields and for the postgraduate looking for a resource to refer to. Chapter authors and editors have selected topics and focused study upon areas chosen for their importance and likely occurrence. This has created a single resource to help inform the reader and prepare them for clinical work.
The book is organised around the human life cycle, beginning with fertilisation and embryological topics, continuing through obstetric medicine, then neonatal care and child health, and ultimately leading into further fertility and gynaecological medicine.
Each chapter begins with a hypothetical clinical case. Each case relates to important aspect(s) of the chapter, intending that the reader considers the problems posed while reading. Every chapter concludes with more information about the case derived from the results of investigations or treatments, and discusses what has occurred and how the person may be treated, and may also discuss likely effects on that person's future.
Topics within the chapter have been organised into chunks, limiting the size of each section and making searching for information easier and faster. Chapters include key information points that summarise the main ideas discussed, and each chapter has an online collection of single best answer (SBA or multiple choice) and extended matching questions (EMQs) to test the reader's understanding. Some of the questions may extend outside the written chapter.
In this way we have aimed to produce a helpful, informative and more concise resource for a wide range of associated topics. This blending of subjects and disciplines matches many modern medical curricula.
Samuel WebsterGeraint MorrisEuan Kevelighan
Every chapter begins with the learning outcomes to the topic.
Case studies give further insight into real-life patient scenarios.
Key learning points give a summary of the topics covered in a chapter.
Your textbook is full of illustrations and tables.
The website icon indicates that you can find accompanying self-assessment resources on the book's companion website.
Don't forget to visit the companion website for this book:
www.wileyessential.com/humandevelopment
There you will find valuable material designed to enhance your learning, including:
Multiple choice questions (MCQs)
Extended matching questions (EMQs)
Sam Webster
Jamie is a 4-month-old boy presenting with disparity between limb length, trunk length and cranial circumference. His height is under the fourth percentile, his weight is under the fourth percentile and his head circumference is above the 97th percentile. Motor development milestones are delayed. Jamie's mother and father have typical heights (168 cm and 176 cm respectively).
You should be able to recognise the stages of cell division in mitosis and meiosis.
You should be able to describe the basic principles of growth and differentiation.
As a basis of biology cell theory is a crucial part of understanding development. Complex organisms grow from a single cell. The cell is the fundamental unit of structure in the organism, and new cells are formed from existing cells. All structure, function and organisation relates to the unit of the cell. In development we consider how the cells of the gametes merge to form a cell with a new genetic composition, the division of that cell to form new cells, and how those cells become organised, form shapes and tissues of multiple differentiated cell types.
DNA is stored in chromatin form within the nuclei of cells, and RNA is present in the cytoplasm. When cells divide the chromosomes are duplicated and the daughter cells gain exact copies of the DNA of the parent cell (hopefully, if the replication and error checking mechanisms work correctly).
Somatic cells contain 23 pairs of chromosomes including 22 pairs of autosomes and one pair of sex chromosomes (Figure 1.1). Each chromosome is an organised package of DNA.
Figure 1.1Human karyotype. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
In a homologous pair of chromosomes the same genes are encoded on each chromosome but the genes may occur as slightly different versions. One chromosome has been inherited from the father, and the other from the mother. For example, the gene for head hair pigment colour will occur on both chromosomes of a homologous pair, but one copy may encode for blonde hair and the other for brown. These copies are alleles, and the dominant pigment allele will be represented in the phenotype of the individual. This is a simplified example, and many hair pigments are at play in determining a person's final hair colour, accounting for the wide variation of natural shades that occurs. The mixing up of alleles across homologous chromosomes during cell division is an important part of the genetic diversity advantage given by sexual reproduction over asexual reproduction.
If a cell has two copies of each kind of chromosome (e.g. one copy from the mother and one copy from the mother) it is said to be diploid. If it only had one copy it would be haploid.
We can also describe a cell by the number of copies (n) of each unique double-stranded length of chromosomal DNA. Chromosomal DNA inherited from the mother is different to chromosomal DNA inherited from the father. In a pair of chromosomes the genes are the same but the alleles are different. A haploid cell has only one copy of each kind of chromosome so it is described as 1n. Somatic cells are normally diploid, and during part of the cell cycle only have one DNA strand for each kind of chromosome so are described as 2n. They have two copies of each kind of chromosome (one from the mother and one from the father). When a cell copies its DNA in preparation for cell division it will have four copies of each kind of chromosome and be described as 4n.
If the DNA strand of a chromosome is duplicated its two duplicates are joined together at the centromere forming the familiar X shape of most chromosomes (Figure 1.2). Each of the two duplicates is a sister chromatid.
Figure 1.2The structure of a chromosome. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
Mitosis is the process by which cells divide and increase in number in eukaryotic organisms. The result of mitosis is two daughter cells that contain the same genetic information. Mitosis is the method by which cells repair tissues, it is one way in which growth can occur, and it is how cells lost through normal processes are replaced. Some cells are very good at proliferating by mitosis, such as epidermal keratinocytes, which are lost daily as flakes of skin, and some cells are very poor at mitotic division, such as neurones of the central nervous system, which are expected to survive for the lifetime of the organism (although it is not yet clearly understood how long neurones live, but they are not naturally replaced after brain damage). Mitosis is a major mechanism of growth in the embryo and fetus.
Cell division is a step within the cell cycle (Figure 1.3). The cell cycle describes a series of carefully controlled events in the life of cell that take part in cell division, and cells that do not divide are considered to have left the cell cycle. The stages of the cell cycle are gap 1 (G1), synthesis (S), gap 2 (G2) and mitosis (M). The stages of G1, S and G2 are also known collectively as interphase. A cell's DNA is duplicated during S phase, adding a sister chromatid to the existing chromatid. A cell that no longer divides can be described as existing within a G0 phase.
Figure 1.3The cell cycle. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
When a cell begins mitosis its chromosomes become condensed and form their recognisable X shapes during the first phase of mitosis, called prophase (Figure 1.4). At this stage it is diploid (4n). Centrioles are cylindrical structures that have a number of functions within eukaryotic cells, and during mitosis they arrange and separate DNA. During prophase the centrioles move to opposite ends of the cell.
Figure 1.4Mitosis. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
In the next stage, prometaphase, the nuclear membrane breaks down and disappears releasing the DNA into the cytoplasm. Microtubules link the centromeres of the chromosomes to the centrioles, and during metaphase the chromosomes begin to move, pulled by the microtubules to line up along the middle of the cell.
The centromeres are cut in the telophase step, splitting each chromosome into its separate, genetically identical chromatids. One of each pair of chromatids is pulled to opposite ends of the cell by microtubules and the centrioles.
In telophase the chromatids reach the ends of the cell, begin to lengthen again and are no longer visible under a light microscope. Two new nuclear membranes begin to form around the chromatid DNA to create two nuclei. Cytokinesis follows during which a ring of actin filaments appears around the midline of the cell and shrinks, splitting the cell into two. Mitosis is complete, and the two cells return to the G1 phase. During the G1 phase each cell has a full, diploid complement of DNA but only one copy of each chromosome (2n).
Meiosis is a specialised method of cell division in eukaryotes that produces gamete cells. The primary function of meiosis is to produce cells with a haploid (n) complement of chromosomes. Somatic cells have two homologous copies of each chromosome (diploid) and gametes have one copy of each chromosome (haploid, n). When the male and female gametes combine during fertilisation the resulting cell has a restored, diploid complement of 23 pairs of chromosomes.
Meiosis is similar to mitosis, but differs in a couple of ways. Cell division occurs twice during a full cycle of meiosis, producing four daughter cells from one cell. Alleles of homologous chromosomes are randomly exchanged between those chromosomes during a process known as homologous recombination. Cells produced as a result of meiosis will have all of the genes of the parent cells (hopefully in the same locations within chromosomes as the parent cells if the process occurs accurately) but with a random allocation of the alleles of those genes. This genetic variability is an important advantage of sexual reproduction over asexual reproduction. If, for example, the original diploid cell contained the allele for a blue iris on one chromosome and the allele for a green iris on the homologous chromosome, any cell formed as a result of meiosis could contain either allele. Alleles of the genes on the same chromosome may or may not be carried across with the allele for iris colour, as homologous recombination maintains the order of genes but alleles may be swapped around.
During S phase the cell's DNA is duplicated. The two parts of meiosis are described as meiosis I and meiosis II. Prophase I begins with homologous recombination of DNA across homologous chromosomes before the chromosomes shorten, thicken and become condensed (Figure 1.5). The centrioles move to either end of the cell and microtubules are extended, beginning to form the mitotic spindle. The cell at this stage has a diploid (4n) complement of DNA. Metaphase I follows, with the chromosomes aligning themselves along the midline of the cell. During anaphase I pairs of homologous chromosomes split up, with one chromosome of each pair pulled to either end of the cell by the mitotic spindle. Each chromosome at this stage is made up of a pair of identical sister chromatids joined together at the centromere. With telophase I , two new nuclear membranes form around the chromosomes that have collected at either end of the cell, forming two nuclei. An actin ring appears around the middle of the cell and constricts, splitting the cell into two daughter cells by cytokinesis. The cells resulting from meiosis I are haploid (2n). They have 23 chromosomes and each chromosome has two chromatids. The chromosomes are not paired at this stage.
Figure 1.5Meiosis. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
In the second part of meiosis the cell goes through division again, beginning with prophase II. The cell's DNA is not duplicated between meiosis I and meiosis II, so it enters the second part with the haploid (2n) complement of chromosomes. Again the chromosomes are in a condensed, thickened configuration and the centrioles move to either end of the cell. In prometaphase II the nuclear membranes break down and microtubules link the chromosomes to the centrioles. The chromosomes become aligned along the middle of the cell during metaphase II, and then the chromosomes are split during anaphase II. The chromosomes are divided into their two sister chromatids, which are each pulled towards opposite ends of the cell. In telophase II the chromatids reach the ends of the cell and nuclear membranes begin to form around them, forming two nuclei. Cytokinesis forms an actin ring around the middle of the cell that contracts and splits the cell into two.
At the end of meiosis four cells have been produced from one, and each cell has 23 unpaired chromosomes. Each cell is haploid (n).
Spermatogenesis describes the development of haploid spermatozoa from germ cells in the testes. The germ cells of the seminiferous tubules are diploid spermatogonia (typically 2n before they duplicate their DNA to 4n for cell division) with a full complement of chromosomes, including X and Y sex chromosomes. Spermatogonia maintain their numbers throughout life by mitotic division.
Spermatogenesis comprises two stages: spermatocytogenesis and spermiogenesis. A type A spermatogonium cell from the pool of proliferating cells will enter the process of maturation, becoming a type B spermatogonium B cell (Figure 1.6). Groups of type B spermatogonia cells begin spermatocytogenesis in synchrony, eventually producing large numbers of mature spermatozoa. Type B spermatogonia cells are linked to one another at this stage by cytoplasmic bridges and divide mitotically, increasing their numbers and becoming primary spermatocytes.
Figure 1.6Spermatogenesis. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
Primary spermatocytes enter the first round of meiotic division (meiosis I). One diploid (4n) primary spermatocyte becomes two haploid (2n) secondary spermatocytes, and a secondary spermatocyte may contain either an X or a Y sex chromosome as part of their complement of 23 chromosomes. During this first round of meiosis homologous recombination of chromosomes occurs.
Secondary spermatocytes divide again through the stages of meiosis II. The resulting cells are spermatids (haploid, n) and four spermatids are derived from one primary spermatocyte. There are 23 unpaired chromosomes within each cell at the end of meiosis II. The spermatid stage marks the end of spermatocytogenesis.
Biological and environmental factors can affect the processes of spermatogenesis, producing abnormal sperm. These factors include smoking, sexually transmitted diseases, toxins, increased testicular temperature and radiation. During semen analysis the spermatozoa are graded by counting the total number of spermatozoa and their concentration, the proportions of motile cells and live cells, and the proportion of abnormal sperm cells. Volume, pH and liquefaction time may also be measured.
The spermatid changes shape, lengthening and forming a rounded head and an elongated tail during the process of spermiogenesis. The tail is packed with mitochondria, the cell loses cytoplasm, and the head contains the nucleus. An acrosome layer of specialised enzymes that will enable penetration of an ovum forms around the head of the cell. With these changes the spermatid becomes a spermatozoon.
These processes of spermatogenesis take around 64 days to produce spermatozoa from spermatogonia A cells, and the spermatozoa remain inactive as they are passed to the epididymis. They continue to mature over a seven-day period within the epididymis, at which point they become motile and ready for fertilisation.
Oogenesis describes the development of haploid oocytes, within follicles, from germ cells in the ovaries. Female germ cells are diploid and contain a pair of X sex chromosomes. They divide mitotically to produce a large number of oogonia, which will enter meiosis (Figure 1.7).
Figure 1.7Oogenesis. (Source: S. Webster and R. de Wreede (2016) Embryology at a Glance, 2nd edn. Reproduced with permission of John Wiley & Sons, Ltd.)
Oogonia begin meiosis I during the 12th week of fetal development. The cell at this stage is known as the primary oocyte, and becomes surrounded by a thin layer of squamous epithelial cells to form a primordial follicle. The primary oocyte only passes through meiosis as far as prophase I with homologous recombination and condensation of the chromosomes (diploid, 4n). The primary oocyte is held, paused in this state. It will only continue its development if it is released from the ovary by ovulation.
Millions of primordial follicles are formed during the first trimester but many degenerate leaving around 400 000 follicles at birth. When puberty begins some of the paused primary oocytes continue their development. Each month a few primordial follicles change. The primary oocyte within becomes larger and the follicular cells become cuboidal. The follicular layer thickens to form a primary follicle. The follicle becomes a secondary follicle when more than one layer of follicle cells has developed. The granulosa cells of the follicle and the oocyte create a layer of glycoproteins on the surface of the oocyte. This layer is the zona pellucida and has important functions during fertilisation (see also Chapter 4).
Although during any particular monthly cycle a number of follicles begin to develop further only one continues leaving the others to degenerate. It is not clear how one follicle is chosen over the others. In the follicle that survives the number of layers of follicular cells continues to increase, and the follicle becomes an antral follicle when it has more than five layers of cells. An antrum appears as a space between the layers of granulosa cells, and this structure becomes the cumulus oophorus.
The follicle is embedded within an ovary, and has been growing and becoming a more prominent structure. The cells of the ovary around the follicle now respond to the follicle's development by differentiating to build two layers of theca interna and theca externa. The follicle is considered to be a mature vesicular follicle (or Graafian follicle). In response to luteinising hormone (LH), thecal cells produce androgens, which are converted into oestrogen. Oestrogens cause repair and thickening of the endometrial lining of the uterus between days 5 and 14 of the menstrual cycle, preparing the endometrium to receive a blastocyst (see Chapter 4).
Only now, in response to spikes in LH and follicle-stimulating hormone (FSH), does the oocyte resume meiosis I and continue in its stalled processes of cell division. At the end of meiosis I the cell divides into a large secondary oocyte (haploid, 2n) and a small polar body (haploid, 2n). The oocyte retains most of its mass and cellular components and the polar body acts as a vessel for the removed chromosomal material. The oocyte is now a haploid cell and the polar body degenerates.
The secondary oocyte enters meiosis II but stalls again, during metaphase II. It will only continue to divide if it is fertilised by a spermatozoon. If this occurs the cell becomes the definitive oocyte (haploid, n, if considered on its own and ignoring the spermatozoon) and produces a second polar body (haploid, n)
If you do the maths and assume that ovulation begins with puberty at around age 11, and ends with menopause at around age 55, at 12 ovulations per year for 44 years only 528 primary oocytes (in this scenario) will continue their development. In truth, only if an oocyte is fertilised by a spermatozoon will it complete meiosis (see Chapter 4), so of the millions of oogonia originally produced only a few are likely to survive.
The arrested development of the primary oocyte in meiosis I may last for 40 or 50 years. Some oocytes will not be stimulated to continue until a menstrual cycle late in reproductive life. The likelihood of DNA fragmentation of a cell increases with time, and DNA fragmentation within these oocytes is more common in older women. This may be the reason for reduced fertility with increasing age.
Biological growth may be defined as an increase in the mass or size of a tissue or organism, and is a key process of development. Growth can occur through three mechanisms: an increase in cell number, an increase in cell size, or an increase in extracellular material.
Cellular proliferation, that is, an increase in cell number through mitotic cell division, is the most common method of achieving growth. The cells of many adult tissues are also able to proliferate, often as part of a repair mechanism in response to injury. Some adult tissues are very good at cellular proliferation, and some are very poor. Stem cells are an important source of cell renewal in tissues that lose cells constantly, such as the epidermis of the skin and the epithelium of the gut.
Cellular hypertrophy describes an increase in cell size, and is a normal part of the endochondral ossification process, for example, in which chondrocytes lay down a cartilaginous precursor that is modified by hypertrophic chondrocytes and replaced by bone. In adult tissues skeletal muscle responds to the repeated loading of weight training with hypertrophy.
Cells of connective tissues secrete and surround themselves with the extracellular matrix that forms much of the tissue. Chondrocytes and osteocytes increase the amount of matrix in response to loading, increasing the size of the tissue by accretion.
Embryological multipotent cells have the potential to form the wide range of cells needed to build the structures and tissues of the embryo. The process of an embryonic stem cell becoming a specialised, determined, mature cell type is differentiation. The differentiated cell type is stable, meaning that cells formed as a result of mitotic division are typically of the same cell type. Differentiated cells do not normally change cell type, but it is possible to take some mature cells and direct them to dedifferentiate and return to a stem-cell-like state in the laboratory. Adult stem cells also exist and are partly differentiated and able to produce a limited number of cell types, often relevant to the tissue in which they reside.
A signal produced by a cell or group of cells is able to influence another cell or group of cells that have receptors for that signal. This is an important concept in embryological development, and much of contemporary research investigates what signals are involved and how they affect cells during development.
Hormones are an example of a signal in adult physiology, and often act in a system-wide manner by passing through the circulatory system from a local source to cells elsewhere in the body. In the embryo the signals may remain attached to the secretory cell or be released to diffuse through the tissue. The distances involved are very small.
Cells respond to the signals in different ways, by differentiating, migrating, proliferating, changing shape, or entering apoptosis, for example.
The first shape that the embryo forms after the embryoblast ball of cells is a flat sheet. The sheet appears to be a uniform, oval plate of cells, and to the eye it would be difficult to guess which end will be the head or the tail, and which side is left and right, yet the cells by this point are organised and will respond to one another to form the structures, cell types, and tissues appropriate to the region they are within and the phase of development.
Cells are aware of their location within the embryo. One way in which this can occur is by the diffusion of signalling molecules synthesised by one group of cells across the tissue, and a variable response to the concentration of that signal by cells with appropriate receptors. The cells may respond differently depending upon whether the concentration of the molecule is high, low or somewhere in between.
Morphogens acting as signals in this way are a fundamental part of development. If this signalling is interfered with it can have profound effects and may prevent the embryo from continuing to develop or cause a congenital abnormality.
The formation of shape during development is morphogenesis. Cells are able to change their shape, extend processes to pull themselves along and migrate, and a tissue may grow in size. These are all processes that occur during development to cause cells to form shapes and structures. The flat sheets of the germ layers roll up in the very early stages of development, forming tubes and spaces, for example.
Jamie is displaying characteristic features of achondroplasia. He has disproportionate short stature, macrocephaly (large cranium), megaloencephaly (large brain), frontal bossing (a prominent forehead), a low nasal bridge, and some facial features are underdeveloped. Jamie has a long trunk and shortened limbs. He has limited elbow extension and forearm supination.
The diagnosis can be further confirmed by radiology and genetic analysis. Radiological investigations will give further insight into specific aspects of Jamie's condition. Jamie will have hypermobile joints and display genu varum (bowed legs). His hearing should be assessed regularly as children with achondroplasia are more likely to develop middle ear infections. Children with achondroplasia are also more likely to have obstructive sleep apnoea.
There is no cure for achondroplasia, and Jamie may develop a number of issues as he grows. It is typically caused by a mutation in the FGFR3 gene that encodes a fibroblast growth factor receptor important in bone and brain growth and development. The mutation is inherited in an autosomal dominant pattern, and only one copy of the defective gene will cause achondroplasia. If two copies of the gene are inherited the developmental defects are likely to be severe enough to cause death, as the thoracic cage is too poorly developed for effective respiration.
In most cases of achondroplasia both parents are of normal height and are not carriers of a defective FGFR3 gene. The cause of achondroplasia in these cases is a spontaneous mutation of the gene.
It is likely that Jamie will develop normal intelligence although developmental milestones will be delayed. Milestones and growth charts for children with achondroplasia can be used to track Jamie's development and growth. He should have a normal lifespan and live independently when he becomes an adult. He may develop spinal and joint problems, or respiratory and cardiovascular difficulties during his development or later in life.
An understanding of spermatogenesis and oogenesis helps explain many causes of subfertility.
Men are able to produce new gametes throughout life, but a woman's ova are all produced before birth and are suspended partway through meiosis until each is selected during an ovulatory cycle. The decision to have children later in life has effects on fertility and on the risk of occurrence of some congenital genetic conditions.
The processes of growth are relevant to embryonic development, fetal growth, childhood development and adolescence. In adults processes of repair are similar.
Now visit www.wileyessential.com/humandevelopment to test yourself on this chapter.
Sam Webster
A 39-year-old woman and her 36-year-old husband present to you in your primary care clinic describing their inability to conceive despite regular, unprotected intercourse for 2 years. You find out that Mrs Amble has a regular 28-day menstrual cycle, that she has never been pregnant, they both have a good understanding of the timings of ovulation and the fertility period, neither smoke nor take recreational drugs, and both drink alcohol occasionally in moderation. Mrs Amble is of normal weight for height and her blood pressure is within the normal range. Mr Amble has never had abdominal or pelvic surgery. She had her appendix removed when she was 15 years old. Neither have a history of urinary tract infections or any sexually transmitted disease, nor diabetes mellitus or thyroid problems. The husband had mumps as a child, and has worked as an electrical engineer for 15 years. Mrs Amble works as a school teacher.
You should be able to recognise the anatomical structures of the female reproductive system and pelvis.
You should be able to describe the physiology of the menstrual cycle.
The pelvis forms initially as three separate bones on either side, joined by cartilage. The three bones are the ilium, the ischium and the pubis (Figure 2.1
